Analysts: Apricus Biosciences Inc (APRI.O)
APRI.O on Consolidated Issue listed on NASDAQ Capital Market
2.65USD
23 May 2013
2.65USD
23 May 2013
Price Change (% chg)
$-0.65 (-19.70%)
$-0.65 (-19.70%)
Prev Close
$3.30
$3.30
Open
$2.80
$2.80
Day's High
$2.80
$2.80
Day's Low
$2.59
$2.59
Volume
4,379,123
4,379,123
Avg. Vol
206,277
206,277
52-wk High
$3.63
$3.63
52-wk Low
$1.89
$1.89
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.12 | December | 23 May 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 0 | 0 | 0 | 1 |
| (2) OUTPERFORM | 4 | 4 | 4 | 4 |
| (3) HOLD | 0 | 0 | 0 | 0 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.00 | 2.00 | 2.00 | 1.80 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-13 | 3 | 1.24 | 3.22 | 0.00 | -- |
| Quarter Ending Sep-13 | 3 | 1.32 | 3.46 | 0.00 | -- |
| Year Ending Dec-13 | 4 | 5.20 | 13.80 | 0.10 | -- |
| Year Ending Dec-14 | 3 | 13.87 | 34.30 | 0.80 | -- |
| Earnings (per share) | |||||
| Quarter Ending Jun-13 | 3 | -0.12 | -0.08 | -0.15 | -- |
| Quarter Ending Sep-13 | 3 | -0.11 | -0.09 | -0.13 | -- |
| Year Ending Dec-13 | 4 | -0.55 | -0.39 | -0.65 | -- |
| Year Ending Dec-14 | 3 | -0.30 | 0.14 | -0.65 | -- |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 1.25 | 1.02 | 0.23 | 18.48 |
| Quarter Ending Dec-12 | 2.37 | 2.50 | 0.13 | 5.53 |
| Quarter Ending Sep-12 | 3.89 | 5.15 | 1.27 | 32.57 |
| Quarter Ending Jun-12 | 2.53 | 0.12 | 2.41 | 95.29 |
| Quarter Ending Dec-11 | 2.02 | 0.12 | 1.90 | 94.10 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | -0.13 | -0.23 | 0.10 | -76.92 |
| Quarter Ending Dec-12 | -0.18 | -0.25 | 0.07 | -36.39 |
| Quarter Ending Sep-12 | -0.08 | -0.09 | 0.02 | -20.00 |
| Quarter Ending Jun-12 | -0.10 | -0.19 | 0.09 | -94.87 |
| Quarter Ending Dec-11 | -0.02 | -0.22 | 0.20 | -1,000.00 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-13 | 1.24 | 1.27 | 2.20 | 3.00 | -- |
| Quarter Ending Sep-13 | 1.32 | 1.35 | 2.20 | 3.00 | -- |
| Year Ending Dec-13 | 5.20 | 5.63 | 8.85 | 15.66 | -- |
| Year Ending Dec-14 | 13.87 | 13.90 | 17.65 | 27.98 | -- |
| Earnings (per share) | |||||
| Quarter Ending Jun-13 | -0.12 | -0.11 | -0.10 | -0.10 | -- |
| Quarter Ending Sep-13 | -0.11 | -0.11 | -0.11 | -0.12 | -- |
| Quarter Ending Dec-13 | -0.55 | -0.50 | -0.44 | -0.38 | -- |
| Quarter Ending Dec-14 | -0.30 | -0.26 | -0.25 | -0.17 | -- |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jun-13 | 0 | 1 | 0 | 2 |
| Quarter Ending Sep-13 | 0 | 1 | 0 | 2 |
| Year Ending Dec-13 | 0 | 1 | 0 | 2 |
| Year Ending Dec-14 | 0 | 1 | 0 | 3 |
| Earnings | ||||
| Quarter Ending Jun-13 | 0 | 1 | 1 | 2 |
| Quarter Ending Sep-13 | 0 | 0 | 1 | 1 |
| Year Ending Dec-13 | 0 | 1 | 0 | 3 |
| Year Ending Dec-14 | 0 | 1 | 0 | 3 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates